Reducing Variability in Cell-Based Methods Using Process Controls

Duration 60 Mins
Level Basic & Intermediate
Webinar ID IQW15C6327

Brief introduction to cell-based methods
Specific areas that may introduce variability in cell-based methods
Value of control charts
Risk associated with lack of monitoring of cells and critical reagents 
Best practices for data entry on control charts
Evaluation of control chart data
Reporting structures 
Inclusion in written test method
Training of analysts

Overview of the webinar

Cell-based methods are known for variability. Living systems introduce complexity not present in simple in vitro methods.  Responses to small changes in reagents, in analyst technique, and in the environment can have a major impact on cell-based systems. Cells are the primary critical reagent in any cell-based system, whether in production or in a test method. As in any method, control of the critical reagent is essential for reducing variability. Proper handling of cells and the implementation of controls that are an integral part of the method can reduce variability in cell-based methods.  Attendees of this webinar will be introduced to concepts designed to assist with developing cell-based methods focused on a reduction in assay failures. We will address understanding sources of variability and examine the critical characteristics of cell-based assays. Specifically, the webinar addresses characterization of the cell line, cell maintenance, culturing cell prior to assay set-up as well as for assay set-up. Although the cells are the primary critical reagent, this webinar will also review other critical reagents important in cell culture and cell-based methods. To assist with monitoring we will discuss intermediate performance controls assessed by control charts. Use of alert and action limits with control charts will also be addressed.  Finally, writing of the methods and training of analysts to decrease variability will be addressed. 

Who should attend?

  • Laboratory personnel (biopharmaceuticals, pharmaceuticals, dietary supplements)
  • Quality assurance personnel (biopharmaceuticals, pharmaceuticals, dietary supplements)
  • Quality control personnel (biopharmaceuticals, pharmaceuticals, dietary supplements)
  • Laboratory managers (biopharmaceuticals, pharmaceuticals, dietary supplements)
  • Manufacturing personnel (biopharmaceuticals, pharmaceuticals, dietary supplements)
  • Method development scientists (biopharmaceuticals, pharmaceuticals, dietary supplements)
  • Method validation scientists (biopharmaceuticals, pharmaceuticals, dietary supplements)
  • Consultants

Why should you attend?

Bioassays are used to demonstrate that a biologic product performs per the stated function and potency. Typically, these methods are performed in living systems. Cell-based methods can have inherent variable due to the nature of living systems. Minimizing potential variability can be achieved through careful documentation and analysis of assay performance on control charts. Monitoring numerous parameters may assist laboratory scientists, laboratory managers, QC and QA personnel identify and manage trends that could lead to OOS/OOT results. Since the number of parameters evaluated is dependent on the cell-type, assay-type, and number of critical component or reagents, this webinar will provide a general overview of the topic as well as specific examples of successful monitoring of cell-based methods leading to a reduction in assay failures.

Faculty - Dr.Gwen Wise-Blackman

Gwen Wise-Blackman has 20 years of combined experience in Cell-Based Assays and Quality Systems.  She has worked at DuPont Pharmaceuticals, Catalent Pharma Solutions (formerly Magellan Laboratories and Cardinal Health), Covance, and Salix Pharmaceuticals.  Her focus has been in High-Throughput Screening, Cell-Based Assay Method Development and Validation, and Quality Assurance.  Gwen has a Bachelor of Science degree in biology from M.I.T and a PhD in Pharmacology from UVa.  She is a member of ASQ and AAPS.

100% MONEY BACK GUARANTEED

Refund / Cancellation policy
For group or any booking support, contact: